Primary human T cells bearing CD16-CAR, with the aforementioned structural changes were co-cultured with EGFR + Panc1 pancreatic cancer cells in the presence of either panitumumab or increasing concentrations of cetuximab. The gene discussed is FCGR3A; the disease is familial pancreatic carcinoma.